Literature DB >> 15950375

Bloom syndrome, genomic instability and cancer: the SOS-like hypothesis.

Mounira Amor-Guéret1.   

Abstract

Bloom syndrome (BS) displays one of the strongest known correlations between chromosomal instability and an increased risk of malignancy at an early age. The prevention of genomic instability and cancer depends on a complex network of pathways induced in response to DNA damage and stalled replication forks, including cell-cycle checkpoints, DNA repair, and apoptosis. Several studies have demonstrated that BLM is involved in the cellular response to DNA damage and stalled replication forks. BLM interacts physically and functionally with several proteins involved in the maintenance of genome integrity and BLM is redistributed and/or phosphorylated in response to several genotoxic stresses. The data concerning the relationship between BLM and these cellular pathways are summarized and the role of BLM in the rescue of arrested replication forks is discussed. Moreover, I speculate that BLM deficiency is lethal, and that BLM-deficient cells escaping apoptotic death do so by constitutively inducing a bacterial SOS-like response including the induction of alternative replication pathway(s) dependent on recombination, contributing to the mutator and hyper-Rec phenotypes characteristic of BS cells. This mechanism may be dependent on the RAD51 gene family, and involved in carcinogenesis in the general population.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15950375     DOI: 10.1016/j.canlet.2005.04.023

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  29 in total

Review 1.  Human pyruvate kinase M2: a multifunctional protein.

Authors:  Vibhor Gupta; Rameshwar N K Bamezai
Journal:  Protein Sci       Date:  2010-11       Impact factor: 6.725

2.  Comprehensive arrayed primer extension array for the detection of 59 sequence variants in 15 conditions prevalent among the (Ashkenazi) Jewish population.

Authors:  Iris Schrijver; Maigi Külm; Phyllis I Gardner; Eugene P Pergament; Morris B Fiddler
Journal:  J Mol Diagn       Date:  2007-04       Impact factor: 5.568

3.  Spontaneous DNA breakage in single living Escherichia coli cells.

Authors:  Jeanine M Pennington; Susan M Rosenberg
Journal:  Nat Genet       Date:  2007-05-27       Impact factor: 38.330

Review 4.  The Fanconi anemia ID2 complex: dueling saxes at the crossroads.

Authors:  Rebecca A Boisvert; Niall G Howlett
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

5.  A novel frameshift mutation in BLM gene associated with high sister chromatid exchanges (SCE) in heterozygous family members.

Authors:  Ghada Ben Salah; Ikhlas Hadj Salem; Abderrahmen Masmoudi; Fakhri Kallabi; Hamida Turki; Faiza Fakhfakh; Hamadi Ayadi; Hassen Kamoun
Journal:  Mol Biol Rep       Date:  2014-08-17       Impact factor: 2.316

Review 6.  Drosophila melanogaster: a model and a tool to investigate malignancy and identify new therapeutics.

Authors:  Cayetano Gonzalez
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

7.  BLM Deficiency Is Not Associated with Sensitivity to Hydroxyurea-Induced Replication Stress.

Authors:  Kenza Lahkim Bennani-Belhaj; Géraldine Buhagiar-Labarchède; Nada Jmari; Rosine Onclercq-Delic; Mounira Amor-Guéret
Journal:  J Nucleic Acids       Date:  2010-09-08

8.  Protein expression of BLM gene and its apoptosis sensitivity in hematopoietic tumor cell strains.

Authors:  Xiaobei Wang; Lihua Hu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2008-02

Review 9.  Phenotypes and genotypes of the chromosomal instability syndromes.

Authors:  Zhan-He Wu
Journal:  Transl Pediatr       Date:  2016-04

10.  The G-quadruplex ligand telomestatin impairs binding of topoisomerase IIIalpha to G-quadruplex-forming oligonucleotides and uncaps telomeres in ALT cells.

Authors:  Nassima Temime-Smaali; Lionel Guittat; Assitan Sidibe; Kazuo Shin-ya; Chantal Trentesaux; Jean-François Riou
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.